Journal of Antimicrobial Chemotherapy logo Oxford University Press logo

The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.

Publisher: Oxford University Press

Volume 44, Number 6, December 1999
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

The use of bacitracin as a growth promoter in animals produces no risk to human health
pp. 725-728(4)

β-Lactams: variations on a chemical theme, with some surprising biological results
pp. 729-734(6)

Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
pp. 735-742(8)
Authors: Tavío, María del Mar; Vila, Jordi; Ruiz, Joaquím; Ruiz, José; Martín-Sánchez, Antonio Manuel

Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii
pp. 743-748(6)
Authors: Navia, Margarita M.; Ruiz, Joaquím; Ribera, Anna; de Anta, M. Teresa Jiménez

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998
pp. 749-759(11)
Authors: Thornsberry, Clyde; Jones, Mark E.; Hickey, Mary L.; Mauriz, Yolanda; Kahn, James

Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and streptococci of Lancefield Groups A and G
pp. 761-766(6)
Authors: MacGowan, Alasdair P.; Bowker, Karen E.; Wootton, Mandy

DNA vaccination by mecA sequence evokes an antibacterial immune response against methicillin-resistant Staphylococcus aureus
pp. 767-774(8)
Authors: Ohwada, Akihiko; Sekiya, Mitsuaki; Hanaki, Hideaki; Arai, Kyoko Kuwahara; Nagaoka, Isao; Hori, Satoshi; Tominaga, Shigeru; Hiramatsu, Keiichi

Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci
pp. 775-786(12)
Authors: Entenza, José M.; Caldelari, Isabelle; Glauser, Michel P.

Antifungal activity of amphotericin B–lipid admixtures in experimental systemic candidosis in naive mice
pp. 787-790(4)
Author: Shadkchan, Yona

Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms
pp. 791-794(4)
Authors: Medda, Swapna; Mukhopadhyay, Sibabrata

The prevalence and clonal expansion of high-level gentamicin-resistant enterococci isolated from blood cultures in a Dutch university hospital
pp. 795-798(4)
Authors: van den Braak, Nicole; van Belkum, Alex; Kreft, Deborah; te Witt, René; Verbrugh, Henri A.

Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial
pp. 799-810(12)
Authors: Geddes, A.; Thaler, M.; Schonwald, S.; Härkönen, M.; Jacobs, F.

Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy
pp. 811-817(7)
Authors: Sendi, Peter P.; Craig, Bruce A.; Meier, Gabriela; Pfluger, Dominik; Gafni, Amiram; Opravil, Milos; Battegay, Manuel; Bucher, Heiner C.

Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria
pp. 819-822(4)
Authors: Andrews, J. M.; Ashby, J. P.; Jevons, G. M.

Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp.
pp. 823-825(3)
Authors: Wainwright, M.; Phoenix, D. A.; Gaskell, M.

In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans
pp. 827-829(3)
Authors: Hossain, Mohammad Ashraf; Maesaki, Shigefumi; Mitsutake, Kotaro; Kakeya, Hiroshi; Sasaki, Eisuke; Tomono, Kazunori; Tashiro, Takayoshi

Modified time–kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations
pp. 831-834(4)
Authors: Messick, Chad R.; Rodvold, Keith A.

Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy
pp. 835-838(4)
Authors: Soman, A.; Honeybourne, D.; Andrews, J.; Jevons, G.

Multiple prescriptions of antibiotics for children aged 0 to 5 years in relation to type of antibiotic
pp. 839-842(4)
Authors: Thrane, Nana; Olesen, Charlotte; Schønheyder, Henrik C.

Assessment of the efficacy, safety and quality of gentamicin use in Aberdeen Royal Infirmary
pp. 843-845(3)
Authors: Buabeng, K. O.; Mackenzie, A. R.; Laing, R. B. S.; Cook, I.; Jappy, B.

Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin
pp. 847-849(3)
Authors: Schmitz, Franz-Josef; Sadurski, Ralf; Stattfeld, Andre; Kray, Angela; Verhoef, Jan; C. Fluit, A.

New BSAC sensitivity testing guidelines
pp. 850-851(2)

Reply
pp. 851-851(1)

In-vitro susceptibilities of Streptococcus pneumoniae strains isolated in Malaysia to six antibiotics
pp. 852-853(2)
Authors: Rohani, M. Y.; Parasakthi, N.; Raudzah, A.

Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women
pp. 854-856(3)
Authors: Sørensen, Henrik Toft; Larsen, Helle; Jensen, Elise Snitker; Thulstrup, Ane Marie; Schønheyder, Henrik C.; Nielsen, Gunnar Lauge; Czeizel, Andrew

Of Mice, Men and Microbes: Hantavirus
pp. 857-857(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A